A detailed history of Russell Investments Group, Ltd. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 2,111 shares of TARS stock, worth $98,478. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,111
Previous 75,876 97.22%
Holding current value
$98,478
Previous $2.06 Million 96.65%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$21.54 - $34.6 $1.59 Million - $2.55 Million
-73,765 Reduced 97.22%
2,111 $69,000
Q2 2024

Aug 08, 2024

BUY
$25.17 - $38.73 $1.15 Million - $1.78 Million
45,840 Added 152.62%
75,876 $2.06 Million
Q1 2024

May 08, 2024

BUY
$19.61 - $39.22 $587,495 - $1.17 Million
29,959 Added 38907.79%
30,036 $1.09 Million
Q4 2023

Feb 05, 2024

BUY
$12.98 - $20.73 $674 - $1,077
52 Added 208.0%
77 $1,000
Q1 2023

May 09, 2023

BUY
$11.92 - $16.27 $298 - $406
25 New
25 $0

Others Institutions Holding TARS

About Tarsus Pharmaceuticals, Inc.


  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $1.24B
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.